Tokyo, Oct 1, 2009 (JCN) - Asahi Kasei begins sales of the Reveal(R) DX insertable cardiac monitor in Japan on October 1, the date the device will be applicable for coverage by Japan's National Health Insurance. Asahi Kasei acquired the exclusive rights for domestic sale of the monitor from Medtronic Japan in July 2008.
The Reveal DX is the first insertable cardiac monitor available in Japan. It is placed beneath the skin of a patient's chest to provide the physician with a high resolution electrocardiogram of the patient's unexplained syncope (fainting spell) to determine if the syncope is caused by an arrhythmia (irregular heartbeat).
Preparations for sales of the Reveal DX are being handled by Asahi Kasei's Advanced Medical Device Center, a new business group at the company. With the initiation of insurance coverage, the device will mainly be sold to medical institutions which specialize in unexplained syncope or arrhythmia. Price will be 422,000 yen per device.
Print
Alerts
